NCT00991406

Brief Summary

The purpose of this research is to find the optimal patterns of functional electrical stimulation (FES) of muscles in the lower legs that will improve walking ability in those who have had a stroke and at the same time ensure walking stability. FES involves applying small electric currents to the nerves, which cause the muscles to contract. FES research projects vary from simple investigations of the therapeutic effects of exercise on muscle function and skin health, to more complex studies of functional movements such as standing or walking.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
9

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jun 2009

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2009

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

October 2, 2009

Completed
6 days until next milestone

First Posted

Study publicly available on registry

October 8, 2009

Completed
6.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2016

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2016

Completed
2.8 years until next milestone

Results Posted

Study results publicly available

August 9, 2019

Completed
Last Updated

August 9, 2019

Status Verified

July 1, 2019

Enrollment Period

7.3 years

First QC Date

October 2, 2009

Results QC Date

June 18, 2019

Last Update Submit

July 18, 2019

Conditions

Keywords

Electric StimulationHemiplegiawalking

Outcome Measures

Primary Outcomes (1)

  • Walking Stability and Speed

    This was a feasibility study of computational models and gait simulations to objectively determine patient-specific patterns of muscle activation. We developed computer models and walking simulations of hemiplegic gait from 8 subjects. We related the model results (muscle activations) to the optimized data collected from hemiplegic subjects \& calculated the FES pattern to be delivered in 2 forms (open loop \& foot switch triggered). The primary outcome measure turned out to be the feasibility of the methods because after developing our computer modeling and computational optimization framework we could only test walking with the 2 forms of FES at the same preferred walking speed on a treadmill. Thus, the simulated walking speed and the real walking speed pre and post FES turned out to be the same. Walking stability was measured with variability in work performed at the ankle. The additional volitional and FES biomechanical data that were measured are listed in the secondary measures.

    pre-stimulation (volitional) and post-stimulation (FES), day of the study

Secondary Outcomes (3)

  • Peak Ankle Power

    Same day: pre-stimulation (volitional) and post-stimulation (FES), day of the study

  • Positive Ankle Work

    Same day; pre-stimulation (volitional) and post-stimulation (FES), day of the study

  • The Impulse of the Anterior Ground Reaction Force Normalized by Body Mass.

    Same day: pre-stimulation (volitional) and post-stimulation (FES), day of the study

Study Arms (1)

Arm 1: FES

EXPERIMENTAL

Case-control study: pre- and post-stimulation (FES).

Device: FES

Interventions

FESDEVICE

Surface stimulation to contract the muscles in the lower extremity

Arm 1: FES

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • This study includes stroke survivors greater than 18 years of age, \>180 days from first clinical hemorrhagic or nonhemorrhagic stroke with:
  • Unilateral hemiparesis with sufficient endurance and motor ability to ambulate \>30 feet continuously without an AFO requiring no more than 25% physical help
  • Berg Balance Scale score \>23 without assistive devices
  • Standing ankle dorsiflexion strength of \<4/5
  • Foot-drop during ambulation with gait instability or inefficient gait defined as supervision need
  • Possible use of physical assistance or assistive device (cane, walker)
  • Evidence of foot-drop as seen by "dragging" or "catching" of affected toes during limb swing or circumducting affected limb
  • Vaulting of the unaffected limb or hiking the affected hip to clear toes.
  • Intact and electrically ex-citable lower motor neurons
  • Ankle dorsiflexion to at least neutral while standing with electrical stimulation of common peroneal and tibial nerves without painful hypersensitivity to stimulation
  • Adequate social support and stability
  • Medically stable with intact skin in affected lower limb
  • Willingness to comply during research procedures
  • No systemic co-morbidities
  • No history of potentially fatal cardiac arrhythmias i.e. ventricular tachycardia, supraventricular tachycardia and rapid ventricular response atrial fibrillation with hemodynamic instability
  • +2 more criteria

You may not qualify if:

  • Requires an ankle foot orthosis (AFO) to prevent knee flexion collapse in stance
  • Excessive edema of affected extremity
  • Absent sensation in affected limb
  • History of potentially fatal cardiac arrhythmias such as ventricular tachycardia, supraventricular tachycardia, and rapid ventricular response, atrial fibrillation with hemodynamic instability
  • Demand pacemakers or any implanted electronic systems
  • Pregnancy
  • Uncontrolled seizure disorder
  • Ipsilateral lower limb lower motor neuron lesion
  • Parkinson's disease
  • Spinal cord injury
  • Traumatic brain injury
  • Multiple sclerosis
  • Ankle plantar flexor contraction
  • Severely impaired cognition and communication
  • Painful hypersensitivity to neuromuscular stimulation of common peroneal nerve
  • +2 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Louis Stokes VA Medical Center, Cleveland, OH

Cleveland, Ohio, 44106, United States

Location

MeSH Terms

Conditions

Hemiplegia

Condition Hierarchy (Ancestors)

ParalysisNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Results Point of Contact

Title
Elizabeth Hardin
Organization
Cleveland VAMC

Study Officials

  • Elizabeth C Hardin van den Bogert, PhD MS

    Louis Stokes VA Medical Center, Cleveland, OH

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
FED
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 2, 2009

First Posted

October 8, 2009

Study Start

June 1, 2009

Primary Completion

September 1, 2016

Study Completion

November 1, 2016

Last Updated

August 9, 2019

Results First Posted

August 9, 2019

Record last verified: 2019-07

Locations